Clinical Trial Update: Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial of Radspherin in colorectal cancer patients with peritoneal carcinomatosis treated with HIPEC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Radspherin

Snippet

Sponsor: Oncoinvent Solutions AS | Conditions: Peritoneal Carcinoma, Colorectal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED